In Search of the Ideal Promotility Agent: Optimal Use of Currently Available Promotility Agents for Nutrition Therapy of the Critically Ill Patient

Sarah Diamond, Endashaw Omer, Laszlo Kiraly

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Purpose of Review: Enteral nutrition therapy is essential in the management of critically ill patients. Prokinetic agents have been used successfully to aid in the delivery of nutrition and improve feeding tolerance in patients in the intensive care unit (ICU). The aim of this report is to review the existing promotility agents available for use in the critically ill as well as outline the role of potential investigative drugs in order to provide a guide to the management of this difficult and important clinical dilemma. Recent Findings: While no single currently available agent currently meets all of the desired goals in the critical care setting, there are an increasing number of available agents from which to choose including motilin receptor agonists, 5HT4 receptor agonists, D2 receptor antagonists, and Mu opioid receptor antagonists. Summary: We recommend a multifaceted approach to optimizing enteral nutrition in the critical care setting which should include the early, prophylactic use of promotility agents and should focus on the management of reversible causes of impaired gastrointestinal motility.

Original languageEnglish (US)
Article number63
JournalCurrent Gastroenterology Reports
Volume19
Issue number12
DOIs
StatePublished - Dec 1 2017

Fingerprint

Nutrition Therapy
Enteral Nutrition
Critical Care
Critical Illness
Gastrointestinal Motility
Narcotic Antagonists
mu Opioid Receptor
Intensive Care Units
Pharmaceutical Preparations
motilin receptor

Keywords

  • Early enteral nutrition
  • Gastrointestinal dysmotility
  • Prokinetics
  • Promotility

ASJC Scopus subject areas

  • Gastroenterology

Cite this

In Search of the Ideal Promotility Agent : Optimal Use of Currently Available Promotility Agents for Nutrition Therapy of the Critically Ill Patient. / Diamond, Sarah; Omer, Endashaw; Kiraly, Laszlo.

In: Current Gastroenterology Reports, Vol. 19, No. 12, 63, 01.12.2017.

Research output: Contribution to journalReview article

@article{83f9ce26f7a54ec79e6fb8dc9d67f7f5,
title = "In Search of the Ideal Promotility Agent: Optimal Use of Currently Available Promotility Agents for Nutrition Therapy of the Critically Ill Patient",
abstract = "Purpose of Review: Enteral nutrition therapy is essential in the management of critically ill patients. Prokinetic agents have been used successfully to aid in the delivery of nutrition and improve feeding tolerance in patients in the intensive care unit (ICU). The aim of this report is to review the existing promotility agents available for use in the critically ill as well as outline the role of potential investigative drugs in order to provide a guide to the management of this difficult and important clinical dilemma. Recent Findings: While no single currently available agent currently meets all of the desired goals in the critical care setting, there are an increasing number of available agents from which to choose including motilin receptor agonists, 5HT4 receptor agonists, D2 receptor antagonists, and Mu opioid receptor antagonists. Summary: We recommend a multifaceted approach to optimizing enteral nutrition in the critical care setting which should include the early, prophylactic use of promotility agents and should focus on the management of reversible causes of impaired gastrointestinal motility.",
keywords = "Early enteral nutrition, Gastrointestinal dysmotility, Prokinetics, Promotility",
author = "Sarah Diamond and Endashaw Omer and Laszlo Kiraly",
year = "2017",
month = "12",
day = "1",
doi = "10.1007/s11894-017-0604-7",
language = "English (US)",
volume = "19",
journal = "Current Gastroenterology Reports",
issn = "1522-8037",
publisher = "Current Medicine Group",
number = "12",

}

TY - JOUR

T1 - In Search of the Ideal Promotility Agent

T2 - Optimal Use of Currently Available Promotility Agents for Nutrition Therapy of the Critically Ill Patient

AU - Diamond, Sarah

AU - Omer, Endashaw

AU - Kiraly, Laszlo

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Purpose of Review: Enteral nutrition therapy is essential in the management of critically ill patients. Prokinetic agents have been used successfully to aid in the delivery of nutrition and improve feeding tolerance in patients in the intensive care unit (ICU). The aim of this report is to review the existing promotility agents available for use in the critically ill as well as outline the role of potential investigative drugs in order to provide a guide to the management of this difficult and important clinical dilemma. Recent Findings: While no single currently available agent currently meets all of the desired goals in the critical care setting, there are an increasing number of available agents from which to choose including motilin receptor agonists, 5HT4 receptor agonists, D2 receptor antagonists, and Mu opioid receptor antagonists. Summary: We recommend a multifaceted approach to optimizing enteral nutrition in the critical care setting which should include the early, prophylactic use of promotility agents and should focus on the management of reversible causes of impaired gastrointestinal motility.

AB - Purpose of Review: Enteral nutrition therapy is essential in the management of critically ill patients. Prokinetic agents have been used successfully to aid in the delivery of nutrition and improve feeding tolerance in patients in the intensive care unit (ICU). The aim of this report is to review the existing promotility agents available for use in the critically ill as well as outline the role of potential investigative drugs in order to provide a guide to the management of this difficult and important clinical dilemma. Recent Findings: While no single currently available agent currently meets all of the desired goals in the critical care setting, there are an increasing number of available agents from which to choose including motilin receptor agonists, 5HT4 receptor agonists, D2 receptor antagonists, and Mu opioid receptor antagonists. Summary: We recommend a multifaceted approach to optimizing enteral nutrition in the critical care setting which should include the early, prophylactic use of promotility agents and should focus on the management of reversible causes of impaired gastrointestinal motility.

KW - Early enteral nutrition

KW - Gastrointestinal dysmotility

KW - Prokinetics

KW - Promotility

UR - http://www.scopus.com/inward/record.url?scp=85035044294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035044294&partnerID=8YFLogxK

U2 - 10.1007/s11894-017-0604-7

DO - 10.1007/s11894-017-0604-7

M3 - Review article

C2 - 29143891

AN - SCOPUS:85035044294

VL - 19

JO - Current Gastroenterology Reports

JF - Current Gastroenterology Reports

SN - 1522-8037

IS - 12

M1 - 63

ER -